A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis
Public ClinicalTrials.gov record NCT03750643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to investigate the safety, tolerability, and efficacy of the study drug known as LY3454738 in healthy participants and participants with atopic dermatitis. The study has three parts. Each participant will enroll in one part. The study will last 12 to 24 weeks, depending on part.
Study identification
- NCT ID
- NCT03750643
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2018 (Actual)
- Primary completion
- Sep 7, 2021 (Actual)
- Completion
- Sep 7, 2021 (Actual)
- Last update posted
- Oct 6, 2021
2018 – 2021
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group | Anniston | Alabama | 36207 | — |
| Arkansas Research Trials, LLC | North Little Rock | Arkansas | 72117 | — |
| Northwest Arkansas Clinical Trials Center | Rogers | Arkansas | 72758 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| California Clinical Trials Medical Group | Glendale | California | 91206 | — |
| Revival Research Corporation | Doral | Florida | 33122 | — |
| Global Health Research Center | Miami Lakes | Florida | 33016 | — |
| ForCare Clinical Research | Tampa | Florida | 33613-1244 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Skin Sciences, PLLC | Louisville | Kentucky | 40217 | — |
| PAREXEL-Phase 1 Baltimore Harbor Hospital Center | Baltimore | Maryland | 21225 | — |
| Detroit Clinical Research Center | Farmington Hills | Michigan | 48334 | — |
| JUVA Skin & Laser Center | New York | New York | 10022-3350 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Wright State Physicians Dermatology | Dayton | Ohio | 46435 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03750643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03750643 live on ClinicalTrials.gov.